3 results
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome) APS ... Venous Thrombosis - Arterial ... #management #EULAR2019 ... #guidelines #rheumatology ... #hematology #treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
• Triggers: ATRA ... treatment Pathophysiology ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... randomized controlled trial ... Anticoagulation #Management ... #Hematology #Oncology